VYOME HOLDINGS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
VYOME HOLDINGS, INC. (HIND) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $67.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-18
- VYOME HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $67.30M, a 17657.26% increase from fiscal 2024.
- VYOME HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $379.00K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $67.30M 10-K · filed 2026-03-18 |
| 2024-12-31 | $379.00K 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |